- About Us
- Science & Technology
- Industries & Market Sectors
- Investor Centre
- Contact Us
OBJ was founded in 2004 after many years working with magnetic induction systems for bone growth stimulation and connective tissue disorders by its Directors and founding shareholders.
Jeffrey Edwards, the Company’s founder, brought together 3 scientist colleagues - Dr Chris Quirk, a well known Dermatologist, Dr Heather Benson, Associate Professor of Pharmacy, Curtin University and Dr John Snowden, an ex-Harvard University protein scientist. Together they created the Company’s first magnetic-enhanced drug delivery system known as Dermaportation.
Since then, OBJ has developed a portfolio of over 20 patents and applications covering the Company’s powered technology, magnetic micro-arrays, enhanced partitioning and penetration technology, and a number of application and industry specific filings.
OBJ has established multiple commercial relationships with leading companies around the world including a multi-product licensing and development agreement with Procter and Gamble in consumer products, exclusive development and collaboration agreements with GSK Consumer Healthcare and GSK Pain Management, and a development agreement with the Coty Group, to name but a few.
The first commercial product to be launched containing OBJ’s magnetic-enhanced delivery technology was the SK-II Eye Wand product, launched in Seoul, South Korea in October 2014.
Glyn has over 30 years experience in international business development including 16 years in technology-intensive industries. Glyn has worked in Europe, China, South-East Asia and Australia, and has extensive networks and contacts across Europe.
Jeff is responsible for scientific and technology development of the Company as well as Business Development and the Company’s International Partnering programs.
Chris has been involved for 25 years in both teaching and research at the University of Western Australia and has worked both in the public and private sector as a consultant dermatologist. Dr Quirk is a Fellow of the Australasian College of Dermatologists and a Member of the American Academy of Dermatology.
John is a Chartered Accountant with 18 years experience in public practice. His areas of expertise are in corporate transaction execution, strategic business management and business structuring. John brings corporate governance and best practice financial management to OBJ.
Jeff is the founder of the Company, developer of the Company’s technology platforms and provides the liaison between partners and OBJ’s laboratory staff.
Matt is responsible for R&D and partnering programs at the technical and implementation level. Matt holds a PhD in chemistry and has many years of experience in diverse fields such as medicinal/pharmaceutical chemistry, biological chemistry, industrial processes and materials. Matt works closely with Jeff Edwards in client support and partnering programs.
George is responsible for the overall management of the Company’s BodyGuard program – an OBJ subsidiary company activity established to develop and market a range of OBJ-developed products targeting joint and pain pathologies. George is a marketing professional with over 15 years experience in the consumer and healthcare industries and works closely with the OBJ team and external contractors to develop and commercialise the BodyGuard products.